France
Abolis Biotechnologies, known for the slogan "Decipher - Innovate - Build," is a French company specializing in the creation of high-impact solutions in the field of biotechnologies. Founded in 2014, the startup has cultivated a team of over 66 experts and focuses on utilizing micro-organisms to offer tailored industrial solutions across various sectors including food, healthcare, cosmetics, and chemicals.
Its approach not only emphasizes the use of renewable raw materials but also aims to relocate essential production to secure supply chains and reduce greenhouse gas emissions. The company prides itself on its multidisciplinary and custom-tailored methodologies, considering science, economics, intellectual property, and industrial realities to address each client's unique challenges.
In its recent funding round, Abolis received a €35.00M late-stage venture capital investment led by notable investors such as ICOS Capital, Clay Capital, LIBERSET, DeepTech & Climate Fonds, Evonik Venture Capital, and L'Oreal BOLD. Positioned as an ambitious and innovative player, Abolis seeks to transform multiple industries, aligning its business model with environmental sustainability and economic viability.
